What is it about?
MERS-CoV is a highly pathogenic pre-pandemic coronavirus transmitted from camels to humans. The spike protein of MERS-CoV uses the cellular protein DPP4 as a receptor for host cell entry. Furthermore, soluble DPP4 can inhibit entry. We obtained indirect evidence that soluble DPP4 is present in blood at concentrations sufficient to inhibit MERS-CoV entry and show that the mutation Q1020R reduces sensitivity to inhibition by soluble DPP4.
Featured Image
Why is it important?
MERS-CoV circulates in African and Arabian camels; however, only viruses from Arabian camels have been found to cause disease in humans. Here, we show that the mutation Q1020R, present in Arabian viruses, confers resistance to soluble DPP4 and may thus help explain why only Arabian viruses have so far been responsible for MERS cases.
Perspectives
A systematic analysis of MERS-CoV resistance development to soluble DPP4 is needed.
Professor Stefan Pöhlmann
German Primate Center
Read the Original
This page is a summary of: Q1020R in the spike proteins of MERS-CoV from Arabian camels confers resistance against soluble human DPP4, Journal of Virology, April 2026, ASM Journals,
DOI: 10.1128/jvi.00282-26.
You can read the full text:
Contributors
The following have contributed to this page







